<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Riboflavin</id>
	<title>Riboflavin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Riboflavin"/>
	<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Riboflavin&amp;action=history"/>
	<updated>2026-05-28T12:10:05Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.46.0-beta</generator>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Riboflavin&amp;diff=6890&amp;oldid=prev</id>
		<title>MDElliottMD: home-claude category backfill (parser-claude gap closure)</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Riboflavin&amp;diff=6890&amp;oldid=prev"/>
		<updated>2026-05-23T10:43:43Z</updated>

		<summary type="html">&lt;p&gt;home-claude category backfill (parser-claude gap closure)&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:43, 23 May 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l21&quot;&gt;Line 21:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 21:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Vitamins]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:B-vitamins]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Riboflavin&amp;diff=6474&amp;oldid=prev</id>
		<title>MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #294</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Riboflavin&amp;diff=6474&amp;oldid=prev"/>
		<updated>2026-05-23T04:15:08Z</updated>

		<summary type="html">&lt;p&gt;parser-claude batch MedTemplate pre-fill, Top 300 #294&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{MedTemplate&lt;br /&gt;
| generic           = Riboflavin (vitamin B2)&lt;br /&gt;
| brand             = Many generics/OTC&lt;br /&gt;
| structure         =&lt;br /&gt;
| classes           = [[:Category:Vitamins|Vitamin]], [[:Category:B-vitamins|B-vitamin]]&lt;br /&gt;
| uses              = &amp;lt;vote slug=&amp;quot;riboflavin-deficiency-use&amp;quot;&amp;gt;Riboflavin deficiency (ariboflavinosis)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;migraine-prophylaxis-use&amp;quot;&amp;gt;Migraine prophylaxis (high-dose, evidence-based)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;hereditary-metabolic-disorders-use&amp;quot;&amp;gt;Selected inborn errors of metabolism (riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency, others)&amp;lt;/vote&amp;gt;&lt;br /&gt;
| starting_dose     = Migraine prophylaxis: 400 mg PO daily; deficiency replacement 5-30 mg/d&lt;br /&gt;
| preparations      = 25, 50, 100, 250, 400 mg tablets; OTC&lt;br /&gt;
| fda_max           = No strict ceiling for water-soluble vitamin; UL not set&lt;br /&gt;
| pill_id           =&lt;br /&gt;
| routes            = Oral, IV (rare)&lt;br /&gt;
| onset             = Migraine effect after 1-3 months of daily use&lt;br /&gt;
| duration          = N/A&lt;br /&gt;
| halflife          = ~1-2 hours plasma (riboflavin itself); FAD/FMN tissue cofactors are continuous&lt;br /&gt;
| bioavailability   = ~50-60% (oral; food enhances)&lt;br /&gt;
| pregnancy         = Safe at replacement and supplement doses.{{citation needed}}&lt;br /&gt;
| legal             = OTC in US&lt;br /&gt;
| mechanism         = &amp;lt;vote slug=&amp;quot;riboflavin-mech-claim&amp;quot;&amp;gt;Riboflavin is the dietary precursor of the flavin cofactors FAD and FMN, which are essential electron carriers for mitochondrial oxidative phosphorylation (complex I and II), fatty acid β-oxidation, and many oxidoreductase reactions; the migraine prophylactic effect is hypothesized to act via improvement of mitochondrial energetics in migraine-susceptible neurons.&amp;lt;/vote&amp;gt; The 400 mg/d dose for migraine prophylaxis is supported by randomized trials (Schoenen 1998) and remains a low-risk evidence-based supplement option. Characteristic bright-yellow urine fluorescence with high-dose oral supplementation.&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
</feed>